Journal
MATURITAS
Volume 80, Issue 4, Pages 370-378Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2015.01.002
Keywords
Baduanjin; Hypertension; Systematic review; Randomized controlled trial
Categories
Funding
- National Natural Science Foundation Project of China [81403375]
Ask authors/readers for more resources
This study aims to evaluate the efficacy of Baduanjin exercise for hypertension. Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang databases were searched. Eight randomized controlled trials (RCTs) were identified. Baduanjin significantly lowered systolic blood pressure (SBP) (WMD = -13.00 mmHg; 95% Cl: -21.24 to -4.77; P = 0.002), diastolic blood pressure (DBP) (WMD = -6.13 mmHg; 95% CI: -11.20 to -1.07; P = 0.02), body mass index, blood glucose, triglyceride, and low-density lipoprotein-cholesterol, and improved high-density lipoprotein-cholesterol and quality of life compared to no intervention. No significant difference between Baduanjin and antihypertensive drugs on SBP (WMD = 1.05 mmHg; 95% Cl: -2.07 to 4.17; P=0.51) or DBP (WMD = 1.90 mmHg; 95% CI: -1.22 to 5.02; P=0.23) was identified. Baduanjin plus antihypertensive drugs significantly reduced SBP (WMD = -7.49 mmHg; 95% CI: -11.39 to -3.59; P = 0.0002), DBP (WMD = -3.55 mmHg; 95% CI: -5.25 to -1.85; P < 0.0001), blood glucose, and total cholesterol compared to antihypertensive drugs. Baduanjin is an effective therapy for hypertension. However, further rigorously designed RCTs are still warranted. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available